These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35138651)

  • 1. COVID-19-associated pulmonary aspergillosis in ICU patients in a German reference centre: Phenotypic and molecular characterisation of Aspergillus fumigatus isolates.
    Kirchhoff L; Braun LM; Schmidt D; Dittmer S; Dedy J; Herbstreit F; Stauf R; Steckel NK; Buer J; Rath PM; Steinmann J; Verhasselt HL
    Mycoses; 2022 Apr; 65(4):458-465. PubMed ID: 35138651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High detection rate of azole-resistant Aspergillus fumigatus after treatment with azole antifungal drugs among patients with chronic pulmonary aspergillosis in a single hospital setting with low azole resistance.
    Takeda K; Suzuki J; Watanabe A; Arai T; Koiwa T; Shinfuku K; Narumoto O; Kawashima M; Fukami T; Tamura A; Nagai H; Matsui H; Kamei K
    Med Mycol; 2021 Apr; 59(4):327-334. PubMed ID: 32642756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.
    Steinmann J; Hamprecht A; Vehreschild MJ; Cornely OA; Buchheidt D; Spiess B; Koldehoff M; Buer J; Meis JF; Rath PM
    J Antimicrob Chemother; 2015 May; 70(5):1522-6. PubMed ID: 25630644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus fumigatus Clinical Isolates Carrying CYP51A with TR34/L98H/S297T/F495I Substitutions Detected after Four-Year Retrospective Azole Resistance Screening in Brazil.
    Pontes L; Beraquet CAG; Arai T; Pigolli GL; Lyra L; Watanabe A; Moretti ML; Schreiber AZ
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.
    Seufert R; Sedlacek L; Kahl B; Hogardt M; Hamprecht A; Haase G; Gunzer F; Haas A; Grauling-Halama S; MacKenzie CR; Essig A; Stehling F; Sutharsan S; Dittmer S; Killengray D; Schmidt D; Eskandarian N; Steinmann E; Buer J; Hagen F; Meis JF; Rath PM; Steinmann J
    J Antimicrob Chemother; 2018 Aug; 73(8):2047-2053. PubMed ID: 29684150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment.
    Astvad KM; Jensen RH; Hassan TM; Mathiasen EG; Thomsen GM; Pedersen UG; Christensen M; Hilberg O; Arendrup MC
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5096-101. PubMed ID: 24936595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus.
    Steenwyk JL; Mead ME; de Castro PA; Valero C; Damasio A; Dos Santos RAC; Labella AL; Li Y; Knowles SL; Raja HA; Oberlies NH; Zhou X; Cornely OA; Fuchs F; Koehler P; Goldman GH; Rokas A
    Microbiol Spectr; 2021 Sep; 9(1):e0001021. PubMed ID: 34106569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.
    Jensen RH; Hagen F; Astvad KM; Tyron A; Meis JF; Arendrup MC
    Clin Microbiol Infect; 2016 Jun; 22(6):570.e1-9. PubMed ID: 27091095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients.
    Fischer J; van Koningsbruggen-Rietschel S; Rietschel E; Vehreschild MJ; Wisplinghoff H; Krönke M; Hamprecht A
    J Antimicrob Chemother; 2014 Jun; 69(6):1533-6. PubMed ID: 24486872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of azole resistance in clinical and environmental strains of Aspergillus fumigatus in Turkey: a multicentre study.
    Ener B; Ergin Ç; Gülmez D; Ağca H; Tikveşli M; Aksoy SA; Otkun M; Siğ AK; Öğünç D; Özhak B; Topaç T; Özdemir A; Metin DY; Polat SH; Öz Y; Koç N; Atalay MA; Erturan Z; Birinci A; Çerikçioğlu N; Timur D; Ekşi F; Genç GE; Findik D; Gürcan Ş; Kalkanci A; Arikan-Akdagli S
    J Antimicrob Chemother; 2022 Jun; 77(7):1894-1898. PubMed ID: 35445259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First azole-resistant Aspergillus fumigatus isolates with the environmental TR
    Ahangarkani F; Puts Y; Nabili M; Khodavaisy S; Moazeni M; Salehi Z; Laal Kargar M; Badali H; Meis JF
    Mycoses; 2020 May; 63(5):430-436. PubMed ID: 32056319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.
    Mohammadi F; Hashemi SJ; Zoll J; Melchers WJ; Rafati H; Dehghan P; Rezaie S; Tolooe A; Tamadon Y; van der Lee HA; Verweij PE; Seyedmousavi S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):387-92. PubMed ID: 26525787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azole resistance in Aspergillus isolates by different types of patients and correlation with environment - An Italian prospective multicentre study (ARiA study).
    Prigitano A; Esposto MC; Grancini A; Biffi A; Innocenti P; Cavanna C; Lallitto F; Mollaschi EMG; Bandettini R; Oltolini C; Passera M; De Lorenzis G; Sargolzaei M; Crespan M; Cogliati M; Tortorano AM; Romanò L
    Mycoses; 2021 May; 64(5):528-536. PubMed ID: 33438319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013.
    van Paassen J; Russcher A; In 't Veld-van Wingerden AW; Verweij PE; Kuijper EJ
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27541498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus fumigatus Isolates from China.
    Chen Y; Lu Z; Zhao J; Zou Z; Gong Y; Qu F; Bao Z; Qiu G; Song M; Zhang Q; Liu L; Hu M; Han X; Tian S; Zhao J; Chen F; Zhang C; Sun Y; Verweij PE; Huang L; Han L
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5878-84. PubMed ID: 27431231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran.
    Badali H; Vaezi A; Haghani I; Yazdanparast SA; Hedayati MT; Mousavi B; Ansari S; Hagen F; Meis JF; Chowdhary A
    Mycoses; 2013 Nov; 56(6):659-63. PubMed ID: 23668594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico.
    Gonzalez-Lara MF; Roman-Montes CM; Diaz-Lomeli P; Rangel-Cordero A; Valenzuela MO; Ponce-de-Leon A; Sifuentes-Osornio J; Ostrosky-Zeichner L; Martinez-Gamboa A
    J Antimicrob Chemother; 2019 Jul; 74(7):2047-2050. PubMed ID: 31220262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Epidemiology Identifies Azole Resistance Due to TR
    Simmons BC; Rhodes J; Rogers TR; Verweij PE; Abdolrasouli A; Schelenz S; Hemmings SJ; Talento AF; Griffin A; Mansfield M; Sheehan D; Bosch T; Fisher MC
    J Fungi (Basel); 2023 Nov; 9(11):. PubMed ID: 37998909
    [No Abstract]   [Full Text] [Related]  

  • 19. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
    Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
    J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients.
    Fuhren J; Voskuil WS; Boel CH; Haas PJ; Hagen F; Meis JF; Kusters JG
    J Antimicrob Chemother; 2015 Oct; 70(10):2894-8. PubMed ID: 26163402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.